4.4 Review

Picornavirus and enterovirus diversity with associated human diseases

Journal

INFECTION GENETICS AND EVOLUTION
Volume 14, Issue -, Pages 282-293

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.meegid.2012.10.016

Keywords

Picomavirus; Enterovirus; Rhinovirus; Diversity; Evolution; Pathogenesis

Funding

  1. Swiss National Science Foundation [310030-127159, 32003B-127160]
  2. Swiss National Science Foundation (SNF) [310030_127159, 32003B_127160] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Members of the Picornaviridae family are non-enveloped, positive-stranded RNA viruses with a 30 nm icosahedral capsid. This virus family exhibits a considerable amount of genetic variability driven both by mutation and recombination. Recently, three previously unknown human picornaviruses, namely the human Saffold cardiovirus, cosavirus and salivirus, have been identified in stools or respiratory samples from subjects presenting symptoms ranging from gastroenteritis to acute flaccid paralysis. However, these viruses were also frequently detected in asymptomatic subjects and their clinical relevance remains to be elucidated. The Enterovirus genus is a prototype example of the Picornaviridae heterogeneity at both genetic and phenotypic levels. This genus is divided into 10 species, seven of which contain human viruses, including three Rhinovirus species. Both human rhino- and enteroviruses are also characterized by high levels of genetic variability, as exemplified by the existence of over 250 different serotypes and the recent discovery of new enterovirus genotypes and the Rhinovirus C species. Despite their common genomic features, rhinoviruses are restricted to the respiratory tract, whereas the vast majority of enteroviruses infect the gastrointestinal tract and can spread to other organs, such as the heart or the central nervous system. Understanding the genetic determinants of such phenotypic diversity is an important challenge and a field for future investigation. Better characterization of these ubiquitous human pathogens may help to develop vaccines or antiviral treatments and to monitor the emergence of new strains. (C) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available